Abstract
In the 1980s, 80% of Canadian hemophiliacs were infected with HIV, hepatitis C or both from tainted blood supplies. As a result, responsibility for the blood system was taken over from the Canadian Red Cross by government agencies. Although blood is now carefully screened in developed countries, health experts worry that blood supplies could become contaminated by emerging pathogens that cannot yet be detected.Chemists from Vitex, a Massachusetts-based company, might have found a way around the problem. Vitex has developed a method of eliminating viruses and bacteria from blood supplies in the first place. The protective agent, a family of molecules termed Inactine™, destroys nucleic acids but leaves red blood cells essentially unchanged. In the first human trials of Inactine™, volunteers suffered no ill effects when re-infused with the treated blood. AVhttp://www.newscientist.com/http://www.cbc.ca/
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
